https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13279 Sat 24 Mar 2018 08:15:16 AEDT ]]> Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29325 Sat 24 Mar 2018 07:34:20 AEDT ]]> Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN) https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52683 Fri 20 Oct 2023 09:51:01 AEDT ]]>